More specifically, inactivating mutations of SMARCB1 are found in all Malignant Rhabdoid Tumors (MRT) and Atypical Teratoid/Rhabdoid Tumors (AT/RT), two highly aggressive forms of pediatric neoplasms [5]. Here, SMARCB1 is linked to childhood neoplasm.